Sherakskin

Sherakskin is a direct-to-consumer, online-only skincare label that concentrates on dermatologist-formulated treatments for hyperpigmentation, acne scars and sun damage. The catalogue spans exfoliating acid serums, barrier-support moisturizers and broad-spectrum mineral SPF, all priced between USD 28–58—solidly mid-range, sitting above drugstore but below luxury clinic brands. Orders are fulfilled exclusively through the brand’s own site, with periodic limited-batch drops announced by email wait-list. The line is built around a patented “Chromalux” peptide complex that interrupts melanin transfer without hydroquinone, making it pregnancy-safe and suitable for deeper skin tones. Bestsellers include the 10% Azelaic + 5% Niacinamide “Spot-Fade” serum and the tinted zinc sunscreen that leaves no cast on Fitzpatrick IV–VI complexions. Every formula is fragrance-free, manufactured in small U.S. FDA-registered labs, and shipped in UV-blocking amber glass to preserve actives. Core buyers are 25-45-year-old women and men with melanin-rich skin who have cycled through harsh brighteners or prescription retinoids without success. They value science-backed, irritation-free solutions and inclusive shade-neutral skincare, often discovering the brand via Reddit skincare threads and derm-led Instagram Lives. Sherakskin competes in the crowded “clinical-grade clean” segment against brands touting high-potency actives and ethical sourcing. It differentiates by focusing narrowly on post-inflammatory hyperpigmentation in medium-to-dark skin, offering chromatic-neutral sunscreens and publishing peer-reviewed pigment research that underpins each launch.